1/6/23 17:48 | 1/5/23 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 0 | 0.00 | 0 | 220 | 34 | 874 | D | | | | | | | | | | | | | | |
1/4/23 16:21 | 12/30/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.dm | 0 | 0.00 | 0 | 120 | 19 | 752 | M | | | | | | | | | | | | | | |
6/3/22 19:04 | 6/3/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 554 | 22.14 | 0 | 25 | 4 | 685 | D | | | | | | | | | | | | | | |
6/3/22 19:04 | 6/3/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -2,308 | 92.34 | 0 | -25 | -4 | 685 | D | | | | | | | | | | | | | | |
6/2/22 16:13 | 5/31/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S | -2,312 | 92.48 | 0 | -25 | -4 | 685 | D | | | | | | | | | | | | | | |
5/20/22 18:15 | 5/20/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 554 | 22.14 | 0 | 25 | 4 | 710 | D | | | | | | | | | | | | | | |
5/20/22 18:15 | 5/20/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -2,250 | 90.00 | 0 | -25 | -3 | 710 | D | | | | | | | | | | | | | | |
5/13/22 16:31 | 5/11/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 390 | 22.14 | 0 | 18 | 3 | 710 | D | | | | | | | | | | | | | | |
5/13/22 16:31 | 5/11/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -1,584 | 90.00 | 0 | -18 | -2 | 710 | D | | | | | | | | | | | | | | |
5/10/22 17:59 | 5/6/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 164 | 22.14 | 0 | 7 | 1 | 710 | D | | | | | | | | | | | | | | |
5/10/22 17:59 | 5/6/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -672 | 90.86 | 0 | -7 | -1 | 710 | D | | | | | | | | | | | | | | |
5/4/22 16:24 | 5/2/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S | -2,401 | 96.04 | 0 | -25 | -3 | 710 | D | | | | | | | | | | | | | | |
4/22/22 18:49 | 4/22/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 554 | 22.14 | 0 | 25 | 4 | 735 | D | | | | | | | | | | | | | | |
4/22/22 18:49 | 4/22/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -2,665 | 106.59 | 0 | -25 | -3 | 735 | D | | | | | | | | | | | | | | |
4/8/22 16:11 | 4/8/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 554 | 22.14 | 0 | 25 | 4 | 735 | D | | | | | | | | | | | | | | |
4/8/22 16:11 | 4/8/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -2,810 | 112.38 | 0 | -25 | -3 | 735 | D | | | | | | | | | | | | | | |
4/1/22 16:10 | 3/30/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S | -5,263 | 105.26 | 0 | -50 | -6 | 735 | D | | | | | | | | | | | | | | |
3/25/22 18:40 | 3/25/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 554 | 22.14 | 0 | 25 | 3 | 785 | D | | | | | | | | | | | | | | |
3/25/22 18:40 | 3/25/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -2,734 | 109.37 | 0 | -25 | -3 | 785 | D | | | | | | | | | | | | | | |
3/11/22 17:17 | 3/11/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 554 | 22.14 | 0 | 25 | 3 | 785 | D | | | | | | | | | | | | | | |
3/11/22 17:17 | 3/11/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -2,523 | 100.93 | 0 | -25 | -3 | 785 | D | | | | | | | | | | | | | | |
2/11/22 16:16 | 2/11/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 554 | 22.14 | 0 | 25 | 3 | 835 | D | | | | | | | | | | | | | | |
2/11/22 16:16 | 2/11/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -2,435 | 97.41 | 0 | -25 | -3 | 835 | D | | | | | | | | | | | | | | |
2/2/22 16:25 | 2/1/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 0 | 0.00 | 0 | 9 | 1 | 835 | I | | | | | | | | | | | | | | |
1/31/22 17:26 | 1/28/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 554 | 22.14 | 0 | 25 | 3 | 829 | D | | | | | | | | | | | | | | |
1/31/22 17:26 | 1/28/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.dm | -11,435 | 91.48 | 0 | -125 | -13 | 829 | D | | | | | | | | | | | | | | |
1/24/22 17:04 | 1/21/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 0 | 0.00 | 0 | 20 | 2 | 929 | D | | | | | | | | | | | | | | |
1/14/22 18:44 | 1/14/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 554 | 22.14 | 0 | 25 | 3 | 918 | D | | | | | | | | | | | | | | |
1/14/22 18:44 | 1/14/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -2,250 | 90.02 | 0 | -25 | -3 | 918 | D | | | | | | | | | | | | | | |
1/6/22 20:56 | 1/5/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 0 | 0.00 | 0 | 250 | 37 | 918 | M | | | | | | | | | | | | | | |
1/4/22 17:00 | 12/31/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | M.d | 554 | 22.14 | 0 | 25 | 4 | 694 | D | | | | | | | | | | | | | | |
1/4/22 17:00 | 12/31/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S.d | -8,105 | 108.07 | 0 | -75 | -10 | 694 | D | | | | | | | | | | | | | | |
12/1/21 17:58 | 11/30/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S | -5,120 | 102.40 | 0 | -50 | -6 | 744 | D | | | | | | | | | | | | | | |
11/3/21 16:30 | 11/1/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S | -2,962 | 118.49 | 0 | -25 | -3 | 794 | M | | | | | | | | | | | | | | |
10/1/21 16:08 | 9/30/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Walbert Timothy P | L2 | DO | CB,P,CEO | S | -5,515 | 110.30 | 0 | -50 | -6 | 819 | M | | | | | | | | | | | | | | |